SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000926617-22-000020
Filing Date
2022-05-02
Accepted
2022-05-02 17:14:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A awh-20220502xdefa14a.htm DEFA14A 13530
2 GRAPHIC awh-20220502xdefa14ag001.jpg GRAPHIC 86158
3 GRAPHIC awh-20220502xdefa14ag002.jpg GRAPHIC 63177
  Complete submission text file 0000926617-22-000020.txt   220788
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34810 | Film No.: 22883210
SIC: 2835 In Vitro & In Vivo Diagnostic Substances